PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2895586-8	1988	The inhibitory action of PYY on 2-DG-stimulated insulin release persisted in the presence of atropine or phentolamine treatment; however, hexamethonium alone or phentolamine plus propranolol treatment blocked the inhibitory action of PYY.	Atropine	93-101	insulin	Canis lupus familiaris	48-55	
3284384-9	1988	During both atropine and pancreatic denervation the cephalic phase of insulin release was suppressed and the NE increase was inhibited by congruent to 65%.	Atropine	12-20	insulin	Canis lupus familiaris	70-77	
8772514-12	1996	Secretin-stimulated (90-210 min) bicarbonate output was diminished by insulin (0.03 +/- 0.01 vs. 0.31 +/- 0.05 meq/10 min; P < 0.003) in INN but not DEN animals; this effect was partially reversed by atropine.	Atropine	203-211	insulin	Canis lupus familiaris	70-77	
3538009-1	1986	The effect of atropine on insulin secretion stimulated by glucose administration in the duodenum was studied in chronic experiments on dogs prior to and following supradiaphragmatic vagotomy.	Atropine	14-22	insulin	Canis lupus familiaris	26-33	
1259480-6	1976	Atropine 0.2 mg/kg abolished the insulin response and at 0.4 mg/kg inhibited (50%) the enzyme response to cholecystokinin; these effects were unaltered by antrectomy or antroneurolysis.	Atropine	0-8	insulin	Canis lupus familiaris	33-40	
4390359-0	1969	Atropine inhibition of insulin-, histamine-, and pentagastrin-stimulated gastric electrolyte and pepsin secretion in the dog.	Atropine	0-8	insulin	Canis lupus familiaris	23-30	
14714611-3	2003	The insulin-releasing activity of motilin in the fed state was completely abolished by pretreatment with atropine or hexamethonium and was partly inhibited by ondansetron.	Atropine	105-113	insulin	Canis lupus familiaris	4-11	
12897820-6	2003	In the presence of atropine with an equivalent dose (128.2 microg) of PACAP(6-27) (500 microg) on a molar basis, the insulin response to PACAP(1-27) was diminished by about 20%, while the glucagon response was enhanced by about 80%.	Atropine	19-27	insulin	Canis lupus familiaris	117-124	
9291842-5	1997	Pretreatment with 20, 100, and 200 micrograms ILV atropine significantly decreased the PP response to insulin-induced hypoglycemia, with the integrated PP response to 58, 32, and 26% of that of controls respectively.	Atropine	50-58	insulin	Canis lupus familiaris	102-109	
6127867-1	1982	Initial atropine resistant vagally mediated decrease of somatostatin levels and increase of gastrin and insulin levels.	Atropine	8-16	insulin	Canis lupus familiaris	104-111	
1208542-3	1975	The potent insulin secretory response elicited by acetylcholine during the 60-min period was abolished 0y 25 muM atropine.	Atropine	113-121	insulin	Canis lupus familiaris	11-18	
1175535-2	1975	Inhibition of the early reflectoric phase of plasma insulin increase through atropine].	Atropine	77-85	insulin	Canis lupus familiaris	52-59	
1109899-7	1975	Pretreatment with atropine inhibited the basal output of glucagon and insulin, but the response of insulin output to splanchnic stimulation was not suppressed, thus excluding the possibility that activation of aberrant parasympathetic nerve fibers located in the splanchnic nerve would be responsible for the delayed increase in insulin  release.	Atropine	18-26	insulin	Canis lupus familiaris	70-77	
9458777-5	1998	Exogenous motilin (0.01-0.3 microgram/kg) dose dependently stimulated insulin release, which was abolished by atropine, hexamethonium, ondansetron, and truncal vagotomy.	Atropine	110-118	insulin	Canis lupus familiaris	70-77	
7937701-5	1994	Intravenous atropine (50 micrograms/kg) did not modify the GIP responses to intraduodenal perfusions of the defined formula diet or to glucose, but did suppress plasma insulin responses to baseline values.	Atropine	12-20	insulin	Canis lupus familiaris	168-175